COCRYSTAL PHARMA, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period
COCRYSTAL PHARMA, INC. (COCP) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period of 22.00 thousand shares for the 6-month period ending 2025-06-30, per its 10-Q filed 2025-08-14.
Financial Statements › Shareholders' Equity › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod · last filed 2025-08-14
- COCRYSTAL PHARMA, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2025-06-30 was 12.00K shares.
- COCRYSTAL PHARMA, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2025-03-31 was 10.00K shares.
- COCRYSTAL PHARMA, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2024-12-31 was 5.00K shares.
- COCRYSTAL PHARMA, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2024 was 8.00K shares.
- COCRYSTAL PHARMA, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2017 was 0.00 shares.
- COCRYSTAL PHARMA, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2016 was 0.00 shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 12 month |
|---|---|---|---|---|
| 2025-06-30 | 12.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | 22.00K shares 10-Q · filed 2025-08-14 | 27.00K shares derived: sum of 3 quarters · filed 2025-08-14 | |
| 2025-03-31 | 10.00K shares 10-Q · filed 2025-05-15 | 15.00K shares derived: sum of 2 quarters · filed 2025-05-15 | ||
| 2024-12-31 | 5.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | 8.00K shares 10-K · filed 2025-03-31 | ||
| 2024-09-30 | 3.00K shares 10-Q · filed 2024-11-13 | |||
| 2017-12-31 | 0.00 shares 10-K · filed 2018-03-21 | |||
| 2016-12-31 | 0.00 shares 10-K · filed 2017-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| ARTELO BIOSCIENCES, INC. (ARTL) | United States | $0.023B | |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| AYTU BIOPHARMA, INC (AYTU) | United States | $0.025B | -1.62 |